Featured Video Play Icon

Experimental Immunotherapy Zaps Two Most Lethal Ebola Virus Strains

First Step Toward All-Inclusive Treatment –┬áResearchers at Albert Einstein College of Medicine and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have engineered the first antibodies that can potently neutralize the two deadliest strains of the virus that causes Ebola hemorrhagic fever. The findings, made in mice, are a significant step toward immunotherapies … Continued